Limit on Royalty Reductions. Notwithstanding anything to the contrary in [***], in no event shall the royalties owed under Section 8.3.1 with respect to a Licensed Product in a country be reduced by operation of Section 8.3.2(a) and (b) by more than [***] percent ([***]%) of what would otherwise be owed under Section 8.3.1 with respect to such Licensed Product in such country. For purposes of clarity, this limitation [***].
Appears in 2 contracts
Samples: Research Collaboration and Exclusive License Agreement (Sigilon Therapeutics, Inc.), Research Collaboration and Exclusive License Agreement (Sigilon Therapeutics, Inc.)
Limit on Royalty Reductions. Notwithstanding anything to the contrary in [***]Sections 4.3.1(a)(ii) and 4.3.1(a)(iii), in no event shall the royalties owed under Section 8.3.1 Sections 4.3.1 with respect to a Licensed Product in a country be reduced by operation of Section 8.3.2(aSections 4.3.1(a)(ii) and (b) 4.3.1(a)(iii), by more than [***] * percent ([***]%) of what would otherwise be owed under Section 8.3.1 4.3.1 with respect to such Licensed Product in such country. For purposes of clarity, this limitation [***].
Appears in 1 contract
Samples: License and Co Commercialization Agreement (Arqule Inc)